Lymphocyte membrane fluidity in peripheral vascular disease patients after treatment with pentoxifylline

C. Motta, F. Conan, M. Roche, M. Thao Chan

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Fluorescence polarization was used to investigate possible modifications of the fluidity and order in lymphocytes membranes from 19 patients treated with pentoxifylline (800 mg/day). We only studied patients with an atherosclerosis obliterans stage II (according Fontaines' classification) having received the drug (pentoxifylline) for 10 days. Anisotropy fluorescence (AF) was measured before and after treatment for each patient using the classical fluorescence probe: 1,6- Diphenyl- 1, 3, 5- Hexatriene (DPH) and the TNBS-DPH quenching method for membrane resolution. Lymphocytes with high values of AF >1.95 (and hence high viscosity) were noticeably modified after the treatment. No similar modifications were observed in cells with original values within the normal range. In these conditions pentoxifylline seems to act only on the perturbated lymphocyte membrane and do not modify the normal membrane. This could be of interest in the modulation and restauration of some immunological properties of membrane proteins under the lymphocyte membrane fluidity dependence.

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalClinical Hemorheology
Volume9
Issue number1
Publication statusPublished - 01-01-1989
Externally publishedYes

Fingerprint

Pentoxifylline
Membrane Fluidity
Peripheral Vascular Diseases
Fluorescence Polarization
Lymphocytes
Membranes
Diphenylhexatriene
Therapeutics
Viscosity
Atherosclerosis
Membrane Proteins
Reference Values
Fluorescence
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Physiology
  • Hematology

Cite this

Motta, C. ; Conan, F. ; Roche, M. ; Thao Chan, M. / Lymphocyte membrane fluidity in peripheral vascular disease patients after treatment with pentoxifylline. In: Clinical Hemorheology. 1989 ; Vol. 9, No. 1. pp. 47-54.
@article{b26b4940c6b44d4d959ffa36bfffee49,
title = "Lymphocyte membrane fluidity in peripheral vascular disease patients after treatment with pentoxifylline",
abstract = "Fluorescence polarization was used to investigate possible modifications of the fluidity and order in lymphocytes membranes from 19 patients treated with pentoxifylline (800 mg/day). We only studied patients with an atherosclerosis obliterans stage II (according Fontaines' classification) having received the drug (pentoxifylline) for 10 days. Anisotropy fluorescence (AF) was measured before and after treatment for each patient using the classical fluorescence probe: 1,6- Diphenyl- 1, 3, 5- Hexatriene (DPH) and the TNBS-DPH quenching method for membrane resolution. Lymphocytes with high values of AF >1.95 (and hence high viscosity) were noticeably modified after the treatment. No similar modifications were observed in cells with original values within the normal range. In these conditions pentoxifylline seems to act only on the perturbated lymphocyte membrane and do not modify the normal membrane. This could be of interest in the modulation and restauration of some immunological properties of membrane proteins under the lymphocyte membrane fluidity dependence.",
author = "C. Motta and F. Conan and M. Roche and {Thao Chan}, M.",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "9",
pages = "47--54",
journal = "Clinical Hemorheology and Microcirculation",
issn = "1386-0291",
publisher = "IOS Press",
number = "1",

}

Lymphocyte membrane fluidity in peripheral vascular disease patients after treatment with pentoxifylline. / Motta, C.; Conan, F.; Roche, M.; Thao Chan, M.

In: Clinical Hemorheology, Vol. 9, No. 1, 01.01.1989, p. 47-54.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lymphocyte membrane fluidity in peripheral vascular disease patients after treatment with pentoxifylline

AU - Motta, C.

AU - Conan, F.

AU - Roche, M.

AU - Thao Chan, M.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Fluorescence polarization was used to investigate possible modifications of the fluidity and order in lymphocytes membranes from 19 patients treated with pentoxifylline (800 mg/day). We only studied patients with an atherosclerosis obliterans stage II (according Fontaines' classification) having received the drug (pentoxifylline) for 10 days. Anisotropy fluorescence (AF) was measured before and after treatment for each patient using the classical fluorescence probe: 1,6- Diphenyl- 1, 3, 5- Hexatriene (DPH) and the TNBS-DPH quenching method for membrane resolution. Lymphocytes with high values of AF >1.95 (and hence high viscosity) were noticeably modified after the treatment. No similar modifications were observed in cells with original values within the normal range. In these conditions pentoxifylline seems to act only on the perturbated lymphocyte membrane and do not modify the normal membrane. This could be of interest in the modulation and restauration of some immunological properties of membrane proteins under the lymphocyte membrane fluidity dependence.

AB - Fluorescence polarization was used to investigate possible modifications of the fluidity and order in lymphocytes membranes from 19 patients treated with pentoxifylline (800 mg/day). We only studied patients with an atherosclerosis obliterans stage II (according Fontaines' classification) having received the drug (pentoxifylline) for 10 days. Anisotropy fluorescence (AF) was measured before and after treatment for each patient using the classical fluorescence probe: 1,6- Diphenyl- 1, 3, 5- Hexatriene (DPH) and the TNBS-DPH quenching method for membrane resolution. Lymphocytes with high values of AF >1.95 (and hence high viscosity) were noticeably modified after the treatment. No similar modifications were observed in cells with original values within the normal range. In these conditions pentoxifylline seems to act only on the perturbated lymphocyte membrane and do not modify the normal membrane. This could be of interest in the modulation and restauration of some immunological properties of membrane proteins under the lymphocyte membrane fluidity dependence.

UR - http://www.scopus.com/inward/record.url?scp=0024450694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024450694&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 47

EP - 54

JO - Clinical Hemorheology and Microcirculation

JF - Clinical Hemorheology and Microcirculation

SN - 1386-0291

IS - 1

ER -